Pruritus in primary biliary cholangitis is under-recorded in patient medical records

被引:3
|
作者
Gungabissoon, Usha [1 ]
Smith, Helen T. [1 ]
von Maltzahn, Robyn [1 ]
Logie, John [1 ]
Fairburn-Beech, Jolyon [1 ]
Ma, Liyuan [2 ]
Dhirishiya, P. [3 ]
McGirr, Ashleigh [4 ]
Hunnicutt, Jake N. [2 ]
Rowe, Christopher L. [5 ]
Tierney, Meghan [5 ]
Friedler, Haley S. [5 ]
机构
[1] GSK, London, England
[2] GSK, Collegeville, PA USA
[3] GSK, Bangalore, India
[4] GSK, Mississauga, ON, Canada
[5] PicnicHlth, San Francisco, CA USA
来源
BMJ OPEN GASTROENTEROLOGY | 2024年 / 11卷 / 01期
关键词
QUALITY OF LIFE; CHOLESTATIC LIVER DISEASES; CHOLESTASIS; HEPATOBILIARY DISEASE; EPIDEMIOLOGY; QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; MANAGEMENT; BEZAFIBRATE; CIRRHOSIS;
D O I
10.1136/bmjgast-2023-001287
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Cholestatic pruritus in primary biliary cholangitis (PBC) reduces patients' health-related quality of life (HRQoL). Despite this, existing research suggests that pruritus is under-recorded in patients' health records. This study assessed the extent to which pruritus was recorded in medical records of patients with PBC as compared with patient-reported pruritus, and whether patients reporting mild itch were less likely to have pruritus recorded. We also evaluated clinico-demographic characteristics and HRQoL of patients with medical record-documented and patient-reported pruritus.Design This cross-sectional study used clinical information abstracted from medical records, together with patient-reported (PBC-40) data from patients with PBC in the USA enrolled in the PicnicHealth cohort. Medical record-documented pruritus was classified as 'recent' (at, or within 12 months prior to, enrolment) or 'ever' (at, or any point prior to, enrolment). Patient-reported pruritus (4-week recall) was assessed using the first PBC-40 questionnaire completed on/after enrolment; pruritus severity was classified by itch domain score (any severity: >= 1; clinically significant itch: >= 7). Patient clinico-demographic characteristics and PBC-40 domain scores were described in patients with medical record-documented and patient-reported pruritus; overlap between groups was evaluated. Descriptive statistics were reported.Results Pruritus of any severity was self-reported by 200/225 (88.9%) patients enrolled; however, only 88/225 (39.1%) had recent medical record-documented pruritus. Clinically significant pruritus was self-reported by 120/225 (53.3%) patients; of these, 64/120 (53.3%) had recent medical record-documented pruritus. Patients reporting clinically significant pruritus appeared to have higher mean scores across PBC-40 domains (indicating reduced HRQoL), versus patients with no/mild patient-reported pruritus or medical-record documented pruritus.Conclusion Compared with patient-reported measures, pruritus in PBC is under-recorded in medical records and is associated with lower HRQoL. Research based only on medical records underestimates the true burden of pruritus, meaning physicians may be unaware of the extent and impact of pruritus, leading to potential undertreatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Diagnosis of primary biliary cholangitis in a "teen" male patient
    Muratori, Paolo
    Lenzi, Marco
    Muratori, Luigi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (02) : E20 - E21
  • [32] A Case of Primary Biliary Cholangitis in a Patient With Multiple Sclerosis
    Kakhktsyan, Tigran
    Aleksanyan, Mesrop
    Acob, Talar
    Hakobyan, Knkush
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [33] A Patient with Primary Sclerosing Cholangitis and Diffuse Biliary Dilation
    Fejleh, M. Phillip
    Yang, Sung-Eun
    Kim, Stephen
    GASTROENTEROLOGY, 2021, 160 (03) : E17 - E18
  • [34] Primary biliary cholangitis in a patient with metastatic breast cancer
    Doello, Kevin
    Trinidad Rueda, Maria
    Amezcua, Victor
    MEDICINA CLINICA, 2021, 156 (03): : 146 - 146
  • [35] A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Kim, Hannah P.
    Lieber, Sarah R.
    Rogers, Michael E.
    Moon, Andrew M.
    Loiselle, Marci
    Walker, Jennifer
    Assis, David N.
    Safer, Ricky
    Gomel, Rachel
    Evon, Donna M.
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (10) : 1502 - 1515
  • [36] PHARMACOLOGICAL THERAPY OF PRURITUS IN PRIMARY BILIARY CHOLANGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Medina-Morales, Esli
    Goyes, Daniela N.
    Gerger, Heike
    Barba, Romelia A.
    Trivedi, Bernal Hirsh
    Patwardhan, Vilas
    Bonder, Alan
    GASTROENTEROLOGY, 2021, 160 (06) : S809 - S810
  • [37] ECONOMIC BURDEN OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND EXPERIENCING FATIGUE OR PRURITUS IN THE UNITED STATES
    Shamseddine, Nisreen
    Yang, Hongbo
    Zhang, Su
    Chen, Jingyi
    Kumar, Sonal
    HEPATOLOGY, 2024, 80 : S1837 - S1837
  • [38] Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review
    Kanda, Tatsuo
    Sasaki-Tanaka, Reina
    Kimura, Naruhiro
    Abe, Hiroyuki
    Yoshida, Tomoaki
    Hayashi, Kazunao
    Sakamaki, Akira
    Yokoo, Takeshi
    Kamimura, Hiroteru
    Tsuchiya, Atsunori
    Kamimura, Kenya
    Terai, Shuji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [39] Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis
    Kremer, Andreas E.
    Mayo, Marlyn J.
    Hirschfield, Gideon M.
    Levy, Cynthia
    Bowlus, Christopher L.
    Jones, David E.
    Johnson, Jeff D.
    McWherter, Charles A.
    Choi, Yun-Jung
    HEPATOLOGY, 2024, 80 (01) : 27 - 37
  • [40] Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis
    Mayo, Marlyn J.
    Carey, Elizabeth
    Smith, Helen T.
    Mospan, Andrea R.
    McLaughlin, Megan
    Thompson, April
    Morris, Heather L.
    Sandefur, Robert
    Kim, W. Ray
    Bowlus, Christopher
    Levy, Cynthia
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (03) : 995 - 1005